Jeffrey M. Goldstein

2.0k total citations
67 papers, 1.6k citations indexed

About

Jeffrey M. Goldstein is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Jeffrey M. Goldstein has authored 67 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cellular and Molecular Neuroscience, 21 papers in Psychiatry and Mental health and 17 papers in Molecular Biology. Recurrent topics in Jeffrey M. Goldstein's work include Schizophrenia research and treatment (15 papers), Neuroscience and Neuropharmacology Research (15 papers) and Neurotransmitter Receptor Influence on Behavior (13 papers). Jeffrey M. Goldstein is often cited by papers focused on Schizophrenia research and treatment (15 papers), Neuroscience and Neuropharmacology Research (15 papers) and Neurotransmitter Receptor Influence on Behavior (13 papers). Jeffrey M. Goldstein collaborates with scholars based in United States, United Kingdom and Canada. Jeffrey M. Goldstein's co-authors include Jeffrey B. Malick, Ming T. Tsuang, Linda Litwin, Becky Kinkead, Charles B. Nemeroff, Lisa A. Arvanitis, A Barnett, Jerome H. Siegel, Robert I. Taber and Allen Barnett and has published in prestigious journals such as Journal of the American Chemical Society, Biological Psychiatry and Brain Research.

In The Last Decade

Jeffrey M. Goldstein

64 papers receiving 1.5k citations

Peers

Countries citing papers authored by Jeffrey M. Goldstein

Since Specialization

Citations

This map shows the geographic impact of Jeffrey M. Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey M. Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey M. Goldstein more than expected).

Fields of papers citing papers by Jeffrey M. Goldstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey M. Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey M. Goldstein. The network helps show where Jeffrey M. Goldstein may publish in the future.

Co-authorship network of co-authors of Jeffrey M. Goldstein

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey M. Goldstein. A scholar is included among the top collaborators of Jeffrey M. Goldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey M. Goldstein. Jeffrey M. Goldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lower Extremity Girth Does Not Predict Complications in TKA 2021 ·The Journal of Arthroplasty ·Eric S. Secrist, (unknown), Jacob M. Drew, Jeffrey M. Goldstein, (unknown), Susan M. Odum, Thomas K. Fehring	4
2	Multiple ipsilateral femoral stress fractures in a patient taking denosumab for osteoporosis—a case report 2020 ·Osteoporosis International ·Hristo Piponov, Jeffrey M. Goldstein, (unknown)	4
3	Humeral head sizing using extra-articular landmarks on conventional radiographs 2017 ·Surgical and Radiologic Anatomy ·David D. Savin, Hristo Piponov, Jeffrey M. Goldstein, Ari R. Youderian	5
4	Alarmingly High Rate of Implant Fractures in One Modular Femoral Stem Design: A Comparison of Two Implants 2017 ·The Journal of Arthroplasty ·(unknown), Jeffrey M. Goldstein, Nancy Cipparrone, Alexander Gordon, (unknown), Wayne Goldstein	11
5	Cystic Adverse Local Tissue Reactions in Asymptomatic Modular Metal-on-Metal Total Hips May Decrease Over Time 2016 ·The Journal of Arthroplasty ·Jeffrey M. Goldstein, Thomas K. Fehring, Keith A. Fehring	15
6	Quetiapine Extended-Release Versus Immediate-Release Formulation 2008 ·The Journal of Clinical Psychiatry ·David C. Mamo, Hiroyuki Uchida, Irina Vitcu, (unknown), Alain Gendron, Jeffrey M. Goldstein, Shitij Kapur	36
7	Neuroanatomic substrates of sex differences in language dysfunction in schizophrenia: A pilot study 2006 ·Schizophrenia Research ·Deborah J. Walder, Larry J. Seidman, Νikolaos Makris, Ming T. Tsuang, David W. Kennedy, Jeffrey M. Goldstein	19
8	Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis 2004 ·Clinical Therapeutics ·Jeffrey M. Goldstein, Bin Huang, (unknown), (unknown)	46
9	Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia 2003 ·Schizophrenia Research ·P.F. Buckley, Jeffrey M. Goldstein, Robin Emsley	25
10	Dosing and switching strategies for quetiapine fumarate 2002 ·Clinical Therapeutics ·Andrew J. Cutler, Jeffrey M. Goldstein, (unknown)	36
11	Impact of Genetic Vulnerability and Hypoxia on Overall Intelligence by Age 7 in Offspring at High Risk for Schizophrenia Compared With Affective Psychoses 2000 ·Schizophrenia Bulletin ·Jeffrey M. Goldstein, L. J. Seidman, Stephen L. Buka, Nicholas J. Horton, (unknown), Ronald O. Rieder, Ming T. Tsuang	50
12	The new generation of antipsychotic drugs: how atypical are they? 2000 ·The International Journal of Neuropsychopharmacology ·Jeffrey M. Goldstein	64
13	ICI 204, 636: A New Atypical Antipsychotic Drug 1996 ·The British Journal of Psychiatry ·Steven R. Hirsch, C.G.G. Link, Jeffrey M. Goldstein, Lisa A. Arvanitis	36
14	Effects of neurotensin on midbrain dopamine neuronal activity 1994 ·Drug Development Research ·Linda Litwin, Jeffrey M. Goldstein	14
15	Seroquel: electrophysiological profile of a potential atypical antipsychotic 1993 ·Psychopharmacology ·Jeffrey M. Goldstein, Linda Litwin, (unknown), Jeffrey B. Malick	88
16	NBQX is a selective non-NMDA receptor antagonist in rat hippocampal slice° 1993 ·Molecular and Chemical Neuropathology ·Jeffrey M. Goldstein, Linda Litwin	18
17	Spontaneous activity of A9 and A10 dopamine neurons after acute and chronic administration of the selective dopamine D-1 receptor antagonist SCH 23390 1988 ·European Journal of Pharmacology ·Jeffrey M. Goldstein, Linda Litwin	16
18	An automated descending rate‐intensity self‐stimulation paradigm: Usefulness for distinguishing antidepressants from neuroleptics 1983 ·Drug Development Research ·Jeffrey M. Goldstein, Jeffrey B. Malick	2
19	Analgesic activity of enkephalins following intracerebral administration in the rat 1977 ·Life Sciences ·Jeffrey B. Malick, Jeffrey M. Goldstein	33
20	Apomorphine-induced hypothermia in mice; a possible dopaminergic effect. 1972 ·PubMed ·A Barnett, Jeffrey M. Goldstein, Robert I. Taber	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact